IP Library › Assignment 044349/0209
Patent Assignment
Reel/Frame 044349/0209

Assignment of Assignor's Interest

Recorded: 2017-11-01 Pages: 4
Assignor
EUTHYMICS BIOSCIENCE, INC.
Executed: 2001-12-22
Assignee
NEUROVANCE, INC.
508 CARNEGIE CENTER DRIVE, PRINCETON, NEW JERSEY, 08540
Covered Properties (3)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Patent: 9,205,074 →
Application: 14/494,512 →
Publication: US 2015/0148399
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Patent: 9,737,506 →
Application: 14/929,361 →
Publication: US 2016/0158197
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application: 15/648,424 →
Publication: US 2018/0000777
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Assignment of Assignor's Interest Nov 1, 2017
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 044349/0078 →
Assignment of Assignor's Interest Nov 1, 2017
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 044002/0396 →
Merger Dec 13, 2017
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 044867/0815 →
Corrective Assignment to Correct the Assignor Execution Previously Recorded on Reel 044349 Frame 0209. Assignor(S) Hereby Confirms the Assignment. May 23, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 046218/0710 →
Merger and Change of Name Jun 27, 2018
From: DOV PHARMACEUTICAL, INC.; EUTHYMICS BIOSCIENCE, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 046446/0132 →